Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

David Ricks, soon to be the new chief executive of Eli Lilly, has set out a bullish forecast for the business over the next five years. Ricks is currently head of Lilly’s Bio-Medicines division ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Eli Lilly and Company (NYSE: LLY) will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on ...

AnalytiXIN has launched a consortium designed to give Indiana researchers better access to health care data—potentially ...

We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...

"We know the supply chain, PBMs are not transparent enough and we should be able to pass through more of that savings directly to consumers," Eli Lilly CEO David Ricks said during a presentation ...